DRMref Logo

Home

Download

Statistics

Landscape

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Datasets with differential expression of this gene

leaf

Expression of this gene in the resistant group across all datasets and cell types

leaf

Significant ligand-receptor pairs related to this gene (This gene does not contain this module)

leaf

Known drug resistance mechanisms of this gene (This gene does not contain this module)

leaf

MicroRNAs (miRNAs) regulating this gene

leaf

Motifs and transcription factors (TFs) regulating this gene

leaf

Acts as a transcription factor (This gene does not contain this module)

leaf

Acts as a drug target

Gene: ACSL4

Summary for ACSL4

Gene informationGene symbol

ACSL4

Ensembl ID

ENSG00000068366

Entrez ID

2182

Gene nameacyl-CoA synthetase long chain family member 4
SynonymsACS4|FACL4|LACS4|MRX63|MRX68
Gene typeprotein_coding
UniProtAcc

O60488


Top

Dataset with differentially expressed gene: ACSL4

check buttonDifferentially expression genes between the resistant and sensitive groups. A positive avg_log2FC represents significantly high expression in the resistant group, while a negative avg_log2FC represents significantly low expression in the resistant group.
DatasetSourceTissueCancer type level1Cancer type level2Drug typeRegimenTimepointCell typeavg_log2FCp_val_adj

GSE207422_Sin

patientsTumor tissueLung cancerEGFR/ALK mutation negative non-small cell lung cancer (NSCLC)Immunotherapysintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)postNeutrophils0.3660486.80e-06

GSE207422_Tor

patientsTumor tissueLung cancerEGFR/ALK mutation negative non-small cell lung cancer (NSCLC)Immunotherapytoripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)postB cells-0.36972.25e-03

GSE199333

patientsBone marrow aspirateAcute myeloid leukemiaPrimary FLT3-ITD-mutated acute myeloid leukemia (AML)Targeted therapygilteritinibpostMalignant cells-0.3275540.00e+00

GSE131984_JQ1

SUM159 cell lineCell lineBreast cancerTriple-negative breast cancer (TNBC)Targeted therapyJQ1NAMalignant cells-0.271754.69e-12

GSE131984_JQ1Pac

SUM159 cell lineCell lineBreast cancerTriple-negative breast cancer (TNBC)Targeted therapyJQ1 + paclitaxelNAMalignant cells-0.2563331.42e-06

GSE131984_JQ1Pal

SUM159 cell lineCell lineBreast cancerTriple-negative breast cancer (TNBC)Targeted therapyJQ1 + palbociclibNAMalignant cells-0.2557523.63e-07

Top

Expression of ACSL4 in the resistant group across all datasets and cell types

check buttonRed dots represent significantly high expression in the resistant group, while blue dots represent significantly low expression in the resistant group. White dots represent that there is no significant difference in the expression of this gene between the resistant and sensitive groups. Blank represents that this cell type is not present in this dataset. (If the image exists, the user can click on it to enlarge it in a new window.)
boxplot

Top

Significant ligand-receptor pairs related to ACSL4

check buttonThis table shows the significant ligand-receptor pairs related to this gene across all datasets, timepoints and conditions. (Complete files can be downloaded from the download section.)

Top

Known drug resistance mechanisms of this gene

check buttonThis table shows the known drug resistance mechanisms of this gene. Clicking on this gene will link to another database that displays more drug resistance-related information.

Top

MicroRNAs (miRNA) regulating ACSL4

check buttonThis table shows the miRNAs with a score of more than 80 regulating this gene. (Complete files can be downloaded from the download section.)
Gene symbolmiRNAScoreGeneBank accession
ACSL4hsa-miR-3200-5p88.0657NM_022977
ACSL4hsa-miR-568487.9012NM_022977
ACSL4hsa-miR-6876-5p87.8626NM_001318509
ACSL4hsa-miR-6869-5p87.8585NM_001318509
ACSL4hsa-miR-6820-3p87.7342NM_001318509
ACSL4hsa-miR-316487.7342NM_001318509
ACSL4hsa-miR-4524a-5p87.6342NM_001318509
ACSL4hsa-miR-612487.5877NM_001318509
ACSL4hsa-miR-34a-5p87.3124NM_001318509
ACSL4hsa-miR-6513-3p86.9965NM_022977
ACSL4hsa-miR-181d-5p86.7733NM_001318509
ACSL4hsa-miR-181a-5p86.7733NM_001318509
ACSL4hsa-miR-181b-5p86.7733NM_001318509
ACSL4hsa-miR-181c-5p86.7733NM_001318509
ACSL4hsa-miR-142-3p86.373NM_001318509
ACSL4hsa-miR-450b-5p86.207NM_022977
ACSL4hsa-miR-366286.1936NM_022977
ACSL4hsa-miR-425585.9817NM_001318509
ACSL4hsa-miR-34c-5p85.7278NM_001318509
ACSL4hsa-miR-520g-5p85.6259NM_022977
ACSL4hsa-miR-62385.1926NM_022977
ACSL4hsa-miR-5004-3p85.1763NM_001318509
ACSL4hsa-miR-5010-3p84.7366NM_022977
ACSL4hsa-miR-342-3p84.6485NM_022977
ACSL4hsa-miR-4668-5p83.9546NM_022977
ACSL4hsa-miR-144-3p83.8191NM_001318509
ACSL4hsa-miR-449a83.6383NM_001318509
ACSL4hsa-miR-4524b-5p83.3753NM_001318509
ACSL4hsa-miR-548c-3p83.122NM_001318509
ACSL4hsa-miR-426382.5327NM_001318509
ACSL4hsa-miR-15a-5p82.3589NM_001318509
ACSL4hsa-miR-15b-5p82.3589NM_001318509
ACSL4hsa-miR-16-5p82.3589NM_001318509
ACSL4hsa-miR-195-5p82.3589NM_001318509
ACSL4hsa-miR-94482.2979NM_001318509
ACSL4hsa-miR-342-5p81.9077NM_001318509
ACSL4hsa-miR-889-5p81.822NM_001318509
ACSL4hsa-miR-316381.6598NM_001318509
ACSL4hsa-miR-208a-5p81.6304NM_022977
ACSL4hsa-miR-208b-5p81.6304NM_022977
ACSL4hsa-miR-1212881.5907NM_022977
ACSL4hsa-miR-520d-5p81.4726NM_001318509
ACSL4hsa-miR-524-5p81.4726NM_001318509
ACSL4hsa-miR-449b-5p81.4721NM_001318509
ACSL4hsa-miR-548k80.7525NM_022977
ACSL4hsa-miR-548av-5p80.7525NM_022977
ACSL4hsa-miR-568080.7217NM_001318509
ACSL4hsa-miR-442280.6551NM_001318509
ACSL4hsa-miR-6835-3p80.6551NM_001318509
ACSL4hsa-miR-150-5p80.5897NM_022977
Page: 1 2 3

Top

Motifs and transcription factors (TFs) regulating ACSL4

check buttonThis table shows the Motifs and transcription factors (TFs) regulating this gene. (Complete files can be downloaded from the download section.)
Gene symbolmotifTF_highConf
ACSL4kznf__ZNF571_Imbeault2017_OM_RCADEZNF571 (directAnnotation).
ACSL4metacluster_144.8ZNF30; ZNF30 (directAnnotation).
ACSL4metacluster_141.5NR3C1; THAP1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY1; YY2; YY2; ZNF597 (directAnnotation). YY1; YY1; YY1; YY2; ZFP42 (inferredBy_Orthology).
ACSL4kznf__ZFP57_Imbeault2017_RP_ChIP-seqZFP57 (directAnnotation).
ACSL4metacluster_144.3ZNF704; ZNF704 (directAnnotation).
ACSL4kznf__ZNF100_Imbeault2017_RP_RCADEZNF100 (directAnnotation).
ACSL4jaspar__MA1721.1ZNF93 (directAnnotation).
ACSL4metacluster_151.2ZNF23 (directAnnotation).
ACSL4metacluster_151.1KAT7; PML; SMAD5; TAF1; ZFP37; ZGPAT; ZNF519; ZNF519; ZNF571; ZNF770; ZNF770; ZNF770; ZSCAN22; ZSCAN22 (directAnnotation).
ACSL4kznf__ZNF548_Imbeault2017_RP_RCADEZNF548 (directAnnotation).
ACSL4dbtfbs__ZBTB8A_HEK293_ENCSR481FEC_merged_N1ZBTB8A (directAnnotation).
ACSL4transfac_pro__M01199TRIM28 (directAnnotation).
ACSL4metacluster_133.1ZNF304; ZNF304; ZSCAN22 (directAnnotation).
ACSL4taipale_tf_pairs__ETV5_HES7_CCGGAANNNNNNCACGTG_CAPETV5; HES7 (directAnnotation).
ACSL4transfac_pro__M01253CNOT3 (directAnnotation).
ACSL4flyfactorsurvey__Mad_FlyReg_FBgn0011648SMAD9 (inferredBy_Orthology).
ACSL4transfac_pro__M02913SP140 (inferredBy_Orthology).
ACSL4dbtfbs__ZNF407_representative_N1ZNF407 (directAnnotation).
ACSL4metacluster_144.5ZNF610; ZNF610; ZNF610 (directAnnotation).
ACSL4taipale_cyt_meth__ZBTB37_NYACCGCRNNYACCGYR_eDBD_meth_reprZBTB37 (directAnnotation).
ACSL4taipale_tf_pairs__TFAP2C_E2F8_NNTCCCGCNNNCCNNNGGC_CAP_reprE2F8; TFAP2C (directAnnotation).
ACSL4cisbp__M00968MTF2 (directAnnotation).
ACSL4metacluster_160.20JUND; PRDM15 (directAnnotation).
ACSL4metacluster_7.13ZFX (directAnnotation).
ACSL4kznf__ZNF783_Imbeault2017_OM_MEMEZNF783 (directAnnotation).
ACSL4swissregulon__hs__CHD1CHD1 (directAnnotation).
ACSL4idmmpmm__MadSMAD9 (inferredBy_Orthology).
ACSL4homer__NANTGCSGCA_Zfp57ZFP57 (directAnnotation).
ACSL4kznf__ZNF383_Imbeault2017_OM_RCADEZNF383 (directAnnotation).
ACSL4transfac_pro__M01090SMAD9 (inferredBy_Orthology).
ACSL4kznf__ZNF90_Imbeault2017_OM_RCADEZNF90 (directAnnotation).
ACSL4metacluster_135.10MBD2; MBD2; MECP2; MECP2 (directAnnotation).
ACSL4kznf__ZNF311_Imbeault2017_OM_MEMEZNF311 (directAnnotation).
ACSL4cisbp__M01863ZNF711 (inferredBy_Orthology).
ACSL4transfac_pro__M07310SP5 (directAnnotation).
ACSL4taipale_cyt_meth__ZNF460_NRMCGCCCCCCGN_eDBD_methZNF460 (directAnnotation).
ACSL4jaspar__MA0535.1SMAD9 (inferredBy_Orthology).
ACSL4transfac_pro__M00938E2F1 (directAnnotation).
ACSL4transfac_pro__M01219SP1 (directAnnotation). SP3 (inferredBy_Orthology).
ACSL4transfac_pro__M04893TAF1 (directAnnotation).
ACSL4metacluster_155.23BCL11B; ZNF711; ZNF711 (directAnnotation). ZFY (inferredBy_Orthology).
ACSL4transfac_pro__M04817ZBTB33 (directAnnotation).
ACSL4transfac_pro__M01088DEAF1 (inferredBy_Orthology).
ACSL4transfac_pro__M12697ZNF142 (directAnnotation).
ACSL4metacluster_175.1ZNF283 (directAnnotation).
ACSL4cisbp__M00788ZFY (inferredBy_Orthology).
ACSL4tfdimers__MD00364WT1 (directAnnotation).
ACSL4metacluster_126.3LIN28B; LIN28B (directAnnotation).
ACSL4transfac_pro__M02865GMEB1 (inferredBy_Orthology).
ACSL4hdpi__ZNF304ZNF304 (directAnnotation).
Page: 1 2 3

Top

Acts as a transcription factor

check buttonThis table shows that this differential gene acts as a transcription factor.

Top

Acts as a drug target

check buttonThis table shows that this differential gene acts as a drug target.
Target nameDrug nameDrug IDDrug type
ACSL4"Icosapent"

DB00159

small molecule
ACSL4"Rosiglitazone"

DB00412

small molecule
ACSL4"Troglitazone"

DB00197

small molecule
Page: 1




1"Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812. PMID: 36243960; PMCID: PMC9825618."
2"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037. PMID: 29126136; PMCID: PMC5753335."